HSS Holds First Rheumatology Gala
The Hospital for Special Surgery (HSS) in New York City hosted a Rheumatology Gala in May. The event, held at The Park Avenue Armory in Manhattan, was held to increase awareness of HSS’s leading research and treatment of rheumatic diseases—particularly with “high-net worth people,” according to former ACR President Mary “Peggy” Crow, MD, chief of the rheumatology division of HSS and one of the featured speakers. “Not that many people know what a rheumatologist is,” she adds. With National Institutes of Health funding low these days, it is increasingly important to raise awareness of rheumatic diseases and their treatments. “The gala was great. Any division could benefit from increasing awareness [of its work],” says Dr. Crow.
In addition to Dr. Crow, speakers included Louis A. Shapiro, CEO & president of HSS; Todd J. Albert, MD, surgeon in chief at HSS; and Susan W. Rose, HSS trustee & co-chair of the Rheumatology Council.
Dr. Crow is a senior research scientist at HSS, with a primary research focus on lupus. That research has been a stimulus to developing new therapies that target interferon by inhibiting its production or blocking its action. She was inducted into the Rheumatology Research Foundation’s Honorary Board of Directors last year at the ACR/ARHP Annual Meeting. While Dr. Crow was president of the ACR from 2005–2006, the ACR donated $5 million to the Foundation to help launch its $30 million Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign. She is also an ACR Master, the highest recognition the College bestows. The title goes to members “who have made outstanding contributions to the field of rheumatology through scholarly achievement and/or service to their patients, students, and profession,” according to the ACR’s website.